Abstract
Emergence of resistance to traditional antibiotic treatments necessitates alternative delivery systems. Teicoplanin is a glycopeptide antibiotic used in the treatments of serious infections caused by Gram-positive bacteria, including Methicillin Resistant Staphylococcus aureus (MRSA). One strategy to keep up with antibiotic resistance development is to limit dose and amount during treatments. Targeted delivery systems of antibiotics have been suggested as a mechanism to slow-down the evolution of resistance and to increase efficiency of the antimicrobials on already resistant pathogens. In this study, we report teicoplanin delivery nanoparticles of Poly Lactic-co-Glycolic Acid (PLGA), which are functionalized with S. aureus specific aptamers. A 32-fold decrease in minimum inhibitory concentration (MIC) values of teicoplanin for S. aureus was demonstrated for susceptible strains and about 64-fold decline in MIC value was achieved for moderately resistant clinical isolates of MRSA upon teicoplanin treatment with aptamer-PLGA nanoparticles. Although teicoplanin delivery in PLGA nanoparticles without targeting demonstrated eightfold decrease in MIC of susceptible strains of S. aureus and S. epidermidis and twofold in MIC of resistant strains, the aptamer targeting specifically decreased MIC for S. aureus, but not for S. epidermidis. Therefore, aptamer-targeted PLGA delivery of antibiotic can be an attractive alternative to combat with some of the multi-drug resistant bacterial pathogens.
Similar content being viewed by others
References
Abu Ammar A, Nasereddin A, Ereqat S, Dan-Goor M, Jaffe CL, Zussman E, Abdeen Z (2019) Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis. Drug Deliv Transl Res 9(1):76–84. https://doi.org/10.1007/s13346-018-00603-0
Agel MR, Baghdan E, Pinnapireddy SR, Lehmann J, Schafer J, Bakowsky U (2019) Curcumin loaded nanoparticles as efficient photoactive formulations against gram-positive and gram-negative bacteria. Colloids Surf B 178:460–468. https://doi.org/10.1016/j.colsurfb.2019.03.027
Baghdan E, Raschpichler M, Lutfi W, Pinnapireddy SR, Pourasghar M, Schafer J, Schneider M, Bakowsky U (2019) Nano spray dried antibacterial coatings for dental implants. Eur J Pharm Biopharm 139:59–67. https://doi.org/10.1016/j.ejpb.2019.03.003
Baptista PV, McCusker MP, Carvalho A, Ferreira DA, Mohan NM, Martins M, Fernandes AR (2018) Nano-strategies to fight multidrug resistant bacteria-"a battle of the titans". Front Microbiol. https://doi.org/10.3389/fmicb.2018.01441
Booysen E, Bezuidenhout M, van Staden AD, Dimitrov D, Deane SM, Dicks LMT (2019) Antibacterial activity of vancomycin encapsulated in poly(DL-lactide-co-glycolide) nanoparticles using electrospraying. Probiotics Antimicro 11(1):310–316. https://doi.org/10.1007/s12602-018-9437-4
Borsa BA, Tuna BG, Hernandez FJ, Hernandez LI, Bayramoglu G, Arica MY, Ozalp VC (2016) Staphylococcus aureus detection in blood samples by silica nanoparticle-oligonucleotides conjugates. Biosens Bioelectron 86:27–32. https://doi.org/10.1016/j.bios.2016.06.023
Cao X, Li S, Chen L, Ding H, Xu H, Huang Y, Li J, Liu N, Cao W, Zhu Y, Shen B, Shao N (2009) Combining use of a panel of ssDNA aptamers in the detection of Staphylococcus aureus. Nucleic Acids Res 37(14):4621–4628. https://doi.org/10.1093/nar/gkp489
Chang Y-C, Yang C-Y, Sun R-L, Cheng Y-F, Kao W-C, Yang P-C (2013) Rapid single cell detection of Staphylococcus aureus by aptamer-conjugated gold nanoparticles. Sci Rep. https://doi.org/10.1038/srep01863
Clinical and Laboratory Standards Institute (2018) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard—10th ed. M07-A11. Clinical and Laboratory Standards Institute, Wayne, PA.
Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V (2012) PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 161(2):505–522. https://doi.org/10.1016/j.jconrel.2012.01.043
Dhal C, Mishra R (2019) Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design. Drug Dev Ind Pharm 45(5):805–818. https://doi.org/10.1080/03639045.2019.1576719
Fang C, Shi B, Pei Y-Y, Hong M-H, Wu J, Chen H-Z (2006) In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle size. Eur J Pharm Sci 27(1):27–36. https://doi.org/10.1016/j.ejps.2005.08.002
Gaspar L, Dorea ACS, Droppa-Almeida D, Silva ISD, Montoro FE, Alves LL, Macedo MLH, Padilha FF (2018) Development and characterization of PLGA nanoparticles containing antibiotics. J Nanopart Res. https://doi.org/10.1007/s11051-018-4387-z
Gaspar MC, Pais A, Sousa JJS, Brillaut J, Olivier JC (2019) Development of levofloxacin-loaded PLGA microspheres of suitable properties for sustained pulmonary release. Int J Pharm 556:117–124. https://doi.org/10.1016/j.ijpharm.2018.12.005
Hsieh Y-C, Lin Y-C, Huang Y-C (2016) Vancomycin, teicoplanin, daptomycin, and linezolid MIC creep in methicillin-resistant Staphylococcus aureus is associated with clonality. Medicine (Baltimore) 95(41):e5060–e5060. https://doi.org/10.1097/MD.0000000000005060
Jia F, Duan N, Wu S, Ma X, Xia Y, Wang Z, Wei X (2014) Impedimetric aptasensor for Staphylococcus aureus based on nanocomposite prepared from reduced graphene oxide and gold nanoparticles. Microchim Acta 181(9):967–974. https://doi.org/10.1007/s00604-014-1195-8
Jin-Wook Y, Elizabeth C, Samir M (2010) Factors that Control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Curr Pharm Des 16(21):2298–2307. https://doi.org/10.2174/138161210791920496
Kavruk M, Celikbicak O, Ozalp VC, Borsa BA, Hernandez FJ, Bayramoglu G, Salih B, Arica MY (2015) Antibiotic loaded nanocapsules functionalized with aptamer gates for targeted destruction of pathogens. Chem Commun 51(40):8492–8495. https://doi.org/10.1039/C5CC01869B
Kim KT, Lee JY, Kim DD, Yoon IS, Cho HJ (2019) recent progress in the development of poly(lactic-co-glycolic acid)-based nanostructures for cancer imaging and therapy. Pharmaceutics 11(6):28. https://doi.org/10.3390/pharmaceutics11060280
Lee N-Y, Ko W-C, Hsueh P-R (2019) Nanoparticles in the treatment of infections caused by multidrug-resistant organisms. Front Pharm. https://doi.org/10.3389/fphar.2019.01153
Li H, Shao S, Cai J, Burner D, Lu L, Chen Q, Minev B, Ma W (2017) Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses. Immunology 152(3):462–471. https://doi.org/10.1111/imm.12783
Lian Y, He F, Wang H, Tong F (2015) A new aptamer/graphene interdigitated gold electrode piezoelectric sensor for rapid and specific detection of Staphylococcus aureus. Biosens Bioelectron 65:314–319. https://doi.org/10.1016/j.bios.2014.10.017
Mairal T, Ozalp VC, Lozano Sanchez P, Mir M, Katakis I, O'Sullivan CK (2008) Aptamers: molecular tools for analytical applications. Anal Bioanal Chem 390(4):989–1007. https://doi.org/10.1007/s00216-007-1346-4
Mariathasan S, Tan M-W (2017) Antibiotic conjugates: a novel therapeutic platform against bacterial infections. Trends Mol Med 23(2):135–149. https://doi.org/10.1016/j.molmed.2016.12.008
Morehead MS, Scarbrough C (2018) Emergence of global antibiotic resistance. Prim Care 45(3):467. https://doi.org/10.1016/j.pop.2018.05.006
Naskar A, Kim K-S (2019) Nanomaterials as delivery vehicles and components of new strategies to combat bacterial infections: advantages and limitations. Microorganisms 7(9):356. https://doi.org/10.3390/microorganisms7090356
Ozalp VC, Bilecen K, Kavruk M, Oktem HA (2013) Antimicrobial aptamers for detection and inhibition of microbial pathogen growth. Future Microbiol 8(3):1–15
Ozalp VC, Kavruk M, Dilek O, Bayrac AT (2015) Aptamers: molecular tools for medical diagnosis. Curr Top Med Chem 15(12):1125–1137
Pei Y, Mohamed MF, Seleem MN, Yeo Y (2017) Particle engineering for intracellular delivery of vancomycin to methicillin-resistant Staphylococcus aureus (MRSA)-infected macrophages. J Control Release 267:133–143. https://doi.org/10.1016/j.jconrel.2017.08.007
Pinto RM, Lopes-de-Campos D, Martins MCL, Van Dijck P, Nunes C, Reis S (2019) Impact of nanosystems in Staphylococcus aureus biofilms treatment. FEMS Microbiol Rev. https://doi.org/10.1093/femsre/fuz021
Powell D, Chandra S, Dodson K, Shaheen F, Wiltz K, Ireland S, Syed M, Dash S, Wiese T, Mandal T, Kundu A (2017) Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer. Eur J Pharm Biopharm 114:108–118. https://doi.org/10.1016/j.ejpb.2017.01.011
Rolston KVI, Dholakia N, Ho DH, LeBlanc B, Dvorak T, Streeter H (1996) In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against Gram-positive clinical isolates from cancer patients. J Antimicrob Chemother 38(2):265–269. https://doi.org/10.1093/jac/38.2.265
Shen J, Jiao Z, Zhou Y, Zhu H, Song Z (2007) Quantification of teicoplanin in human plasma by liquid chromatography with ultraviolet detection. Chromatographia 65(1):9–12. https://doi.org/10.1365/s10337-006-0115-4
Stapleton PD, Taylor PW (2002) Methicillin resistance in Staphylococcus aureus: mechanisms and modulation. Sci Prog 85(Pt 1):57–72
Tsai C-Y, Lee C-H, Chien C-C, Chen IL (2018) Impact of teicoplanin maintenance dose and MIC values on the clinical outcomes of patients treated for methicillin-resistant Staphylococcus aureus bacteremia. Infect Drug Resist 11:1205–1217. https://doi.org/10.2147/IDR.S171236
Vahed ZS, Fathi N, Samiei M, Maleki Dizaj S, Sharifi S (2019) Targeted cancer drug delivery with aptamer-functionalized polymeric nanoparticles. J Drug Targ 27(3):292–299. https://doi.org/10.1080/1061186x.2018.1491978
Vallet-Regí M, González B, Izquierdo-Barba I (2019) Nanomaterials as promising alternative in the infection treatment. Int J Mol Sci 20(15):3806. https://doi.org/10.3390/ijms20153806
Vaudaux P, Huggler E, Bernard L, Ferry T, Renzoni A, Lew DP (2010) Underestimation of vancomycin and teicoplanin MICs by Broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus. Antimicrob Agents Chemother 54(9):3861–3870. https://doi.org/10.1128/aac.00269-10
Wang L, Wang R, Wei H, Li Y (2018) Selection of aptamers against pathogenic bacteria and their diagnostics application. World J Microbiol Biotech 34(10):149. https://doi.org/10.1007/s11274-018-2528-2
Xu WK, Tang JY, Yuan Z, Cai CY, Chen XB, Cui SQ, Liu P, Yu L, Cai KY, Ding JD (2019) accelerated cutaneous wound healing using an injectable teicoplanin-loaded PLGA-PEG-PLGA thermogel dressing. Chin J Polym Sci 37(6):548–559. https://doi.org/10.1007/s10118-019-2212-5
Zakeri-Milani P, Loveymi BD, Jelvehgari M, Valizadeh H (2013) The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system. Colloids Surf B 103:174–181. https://doi.org/10.1016/j.colsurfb.2012.10.021
Zhou G, Latchoumanin O, Hebbard L, Duan W, Liddle C, George J, Qiao L (2018) Aptamers as targeting ligands and therapeutic molecules for overcoming drug resistance in cancers. Adv Drug Deliv Rev 134:107–121. https://doi.org/10.1016/j.addr.2018.04.005
Acknowledgements
This work was supported by Research Fund of the Yildiz Technical University. Project Number: FDK-2018-3244.
Funding
This study was funded by Yildiz Technical University (Grant No. FDK-2018–3244).
Author information
Authors and Affiliations
Contributions
SU and MS, BAB carried out the experiments, VCO, BM and BAB designed the experiments, SU and VCO wrote the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Authors declares that they have no conflict of interest.
Research involving human and animal rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ucak, S., Sudagidan, M., Borsa, B.A. et al. Inhibitory effects of aptamer targeted teicoplanin encapsulated PLGA nanoparticles for Staphylococcus aureus strains. World J Microbiol Biotechnol 36, 69 (2020). https://doi.org/10.1007/s11274-020-02845-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11274-020-02845-y